Intercept to Present at the Bank of America Merrill Lynch Virtual Global Healthcare Conference
May 06 2020 - 8:30AM
Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical
company focused on the development and commercialization of novel
therapeutics to treat progressive non-viral liver diseases, today
announced that Mark Pruzanski, M.D., President and Chief Executive
Officer of Intercept, will present at the Bank of America Merrill
Lynch Virtual Global Healthcare Conference on Wednesday, May 13,
2020 at 2:20 p.m. ET.
A live webcast of the event will be available on the investor
page of Intercept’s website at http://ir.interceptpharma.com. An
audio archive of the webcast will also be available on Intercept’s
website for approximately two weeks.
About InterceptIntercept is a biopharmaceutical
company focused on the development and commercialization of novel
therapeutics to treat progressive non-viral liver diseases,
including primary biliary cholangitis (PBC) and nonalcoholic
steatohepatitis (NASH). Founded in 2002 in New York, Intercept has
operations in the United States, Europe and Canada. For more
information, please visit www.interceptpharma.com or connect with
the company on Twitter and LinkedIn.
CONTACT
For more information about Intercept, please contact:
Investor inquiries: investors@interceptpharma.com
Media inquiries: media@interceptpharma.com
Source: Intercept Pharmaceuticals, Inc.
Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
From Apr 2023 to Apr 2024